Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Havn Life Sciences Inc (HAVN.CN)

Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Havn Life Sciences Inc 605 - 130 Brew Street Port Moody BC V3H 0E3 CAN

https://www.havnlife.com P: 604-639-2143

Description:

HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

Key Statistics

Overview:

Market Capitalization, $K 442
Shares Outstanding, K 14,739
Annual Sales, $ 276 K
Annual Net Income, $ -22,444 K
Last Quarter Sales, $ -12 K
Last Quarter Net Income, $ -692 K
60-Month Beta -0.92
% of Institutional Shareholders 0.02%

Growth:

1-Year Return -66.67%
3-Year Return -99.89%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -3.11
EPS Growth vs. Prev Year 395.12%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 08/03/22

HAVN.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -234.52%
Return-on-Assets % -211.59%
Profit Margin % -8,117.81%
Debt/Equity 0.10
Price/Sales 0.36
Price/Book 0.53
Book Value/Share 0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar